Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |